Epigral Past Earnings Performance
Past criteria checks 2/6
Epigral has been growing earnings at an average annual rate of 10.8%, while the Chemicals industry saw earnings growing at 16.6% annually. Revenues have been growing at an average rate of 21.1% per year. Epigral's return on equity is 15.6%, and it has net margins of 10.2%.
Key information
10.8%
Earnings growth rate
15.2%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | 21.1% |
| Return on equity | 15.6% |
| Net Margin | 10.2% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Epigral Limited (NSE:EPIGRAL) Looks Just Right With A 27% Price Jump
Apr 19
Epigral Limited (NSE:EPIGRAL) Soars 28% But It's A Story Of Risk Vs Reward
Feb 23Epigral (NSE:EPIGRAL) Might Be Having Difficulty Using Its Capital Effectively
Feb 21Capital Investment Trends At Meghmani Finechem (NSE:MFL) Look Strong
Apr 05With EPS Growth And More, Meghmani Finechem (NSE:MFL) Makes An Interesting Case
Sep 28Meghmani Finechem's (NSE:MFL) Promising Earnings May Rest On Soft Foundations
May 03Meghmani Finechem Limited's (NSE:MFL) Business Is Yet to Catch Up With Its Share Price
Nov 22Revenue & Expenses BreakdownBeta
How Epigral makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 19,292 | 1,958 | 897 | 0 |
| 31 Dec 23 | 19,667 | 1,953 | 887 | 0 |
| 30 Sep 23 | 20,331 | 2,234 | 871 | 0 |
| 30 Jun 23 | 21,104 | 2,770 | 865 | 0 |
| 31 Mar 23 | 21,884 | 3,533 | 886 | 0 |
| 31 Dec 22 | 21,250 | 3,756 | 924 | 0 |
| 30 Sep 22 | 20,093 | 3,682 | 895 | 0 |
| 30 Jun 22 | 17,934 | 3,236 | 848 | 0 |
| 31 Mar 22 | 15,509 | 2,528 | 768 | 0 |
| 31 Mar 21 | 8,286 | 1,008 | 536 | 0 |
| 31 Mar 20 | 6,098 | 1,141 | 441 | 0 |
| 31 Mar 19 | 7,104 | 1,828 | 482 | 0 |
| 31 Mar 18 | 5,975 | 1,555 | 371 | 0 |
| 31 Mar 17 | 3,921 | 665 | 150 | 0 |
| 31 Mar 16 | 3,982 | 672 | 120 | 0 |
| 31 Mar 15 | 3,518 | 347 | 102 | 0 |
Quality Earnings: EPIGRAL has high quality earnings.
Growing Profit Margin: EPIGRAL's current net profit margins (10.2%) are lower than last year (16.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EPIGRAL's earnings have grown by 10.8% per year over the past 5 years.
Accelerating Growth: EPIGRAL's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: EPIGRAL had negative earnings growth (-44.6%) over the past year, making it difficult to compare to the Chemicals industry average (-6.1%).
Return on Equity
High ROE: EPIGRAL's Return on Equity (15.6%) is considered low.